$0.45 EPS Expected for Quidel Corporation (QDEL)

January 23, 2018 - By Migdalia James

 $0.45 EPS Expected for Quidel Corporation (QDEL)
Investors sentiment decreased to 1.2 in 2017 Q3. Its down 1.21, from 2.41 in 2017Q2. It worsened, as 24 investors sold Quidel Corporation shares while 32 reduced holdings. 33 funds opened positions while 34 raised stakes. 30.68 million shares or 6.86% more from 28.71 million shares in 2017Q2 were reported.
Renaissance Techs Llc holds 0.04% or 832,087 shares in its portfolio. First Mercantile invested 0.05% of its portfolio in Quidel Corporation (NASDAQ:QDEL). Wellington Limited Liability Partnership has 0% invested in Quidel Corporation (NASDAQ:QDEL). Chicago Equity Prtnrs Ltd has 0.01% invested in Quidel Corporation (NASDAQ:QDEL). Moreover, Voya Mgmt Ltd Liability Co has 0% invested in Quidel Corporation (NASDAQ:QDEL) for 13,636 shares. Barclays Pcl invested in 6,047 shares or 0% of the stock. Vanguard Grp Inc, a Pennsylvania-based fund reported 2.33 million shares. Pacad Inv Ltd reported 0.03% stake. Davidson Kempner Capital Mngmt Ltd Partnership reported 159,045 shares. Dimensional Fund Lp has invested 0.02% in Quidel Corporation (NASDAQ:QDEL). Omni Prtn Limited Liability Partnership has invested 0.82% in Quidel Corporation (NASDAQ:QDEL). Ny State Common Retirement Fund has invested 0.05% in Quidel Corporation (NASDAQ:QDEL). 4,469 were reported by Peak6 L P. Royal Fincl Bank Of Canada invested 0% in Quidel Corporation (NASDAQ:QDEL). Price T Rowe Associate Md, Maryland-based fund reported 3.36M shares.

Since August 29, 2017, it had 0 buys, and 8 sales for $12.34 million activity. 29,880 shares were sold by BORKAR RATAN S, worth $1.35M on Wednesday, January 3. $4.40 million worth of Quidel Corporation (NASDAQ:QDEL) was sold by Bujarski Robert Joseph on Friday, December 15. $661,529 worth of Quidel Corporation (NASDAQ:QDEL) shares were sold by Kroll Werner. STEWARD RANDALL J also sold $1.46M worth of Quidel Corporation (NASDAQ:QDEL) on Tuesday, December 12. $188,080 worth of Quidel Corporation (NASDAQ:QDEL) shares were sold by SCHULER JACK W.

Analysts expect Quidel Corporation (NASDAQ:QDEL) to report $0.45 EPS on February, 14.They anticipate $0.35 EPS change or 350.00 % from last quarter’s $0.1 EPS. QDEL’s profit would be $15.30M giving it 26.60 P/E if the $0.45 EPS is correct. After having $-0.16 EPS previously, Quidel Corporation’s analysts see -381.25 % EPS growth. The stock decreased 0.37% or $0.18 during the last trading session, reaching $47.88. About 74,664 shares traded. Quidel Corporation (NASDAQ:QDEL) has risen 56.78% since January 23, 2017 and is uptrending. It has outperformed by 40.08% the S&P500.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 9 analysts covering Quidel (NASDAQ:QDEL), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Quidel had 30 analyst reports since September 2, 2015 according to SRatingsIntel. The company was initiated on Friday, February 17 by CL King. The rating was maintained by Canaccord Genuity on Tuesday, September 19 with “Buy”. Barclays Capital maintained it with “Overweight” rating and $49 target in Thursday, November 2 report. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, January 2 report. William Blair upgraded Quidel Corporation (NASDAQ:QDEL) on Tuesday, July 18 to “Outperform” rating. The company was downgraded on Friday, October 23 by Craig Hallum. Canaccord Genuity maintained Quidel Corporation (NASDAQ:QDEL) on Thursday, December 21 with “Buy” rating. The firm earned “Buy” rating on Tuesday, July 18 by Canaccord Genuity. The stock has “Hold” rating by Canaccord Genuity on Tuesday, February 9. Canaccord Genuity maintained Quidel Corporation (NASDAQ:QDEL) on Tuesday, October 24 with “Buy” rating.

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC women??s and general health, and gastrointestinal diseases. The company has market cap of $1.63 billion. The firm offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus , QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It currently has negative earnings. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S.

More news for Quidel Corporation (NASDAQ:QDEL) were recently published by: Businesswire.com, which released: “Quidel Completes Sale Leaseback of Summers Ridge Property for $148.65 Million” on January 05, 2018. Fool.com‘s article titled: “Why Quidel Corporation Is Sinking” and published on November 27, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.